LE WE PMID CA
Diabetes mellitus (t Insulin Analogs)1331Diabetes mellitus (t Insulin Analoga)

Albumin

Diabetes mellitus (t Insulin Analogs)

Diabetes mellitus (t Insulin Inhalative)

Diabetes mellitus T2DM (Type2)

Exenatide

Neoplasia (Therapy related)

Sitagliptin

Vildagliptin

2002  
1
Insulin glargine: a new basal insulin analogue.
[12391389] QJM 95(11): 757-61 (2002)
2008  
2
Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence.
[18801953] Clin Med Res 6(2): 54-67 (2008)
2006  
3
Innovative insulins--where do analogues fit?
[17149471] Aust Fam Physician 35(12): 969-73 (2006)
2009  
4
Insulin analog therapy: improving the match with physiologic insulin secretion.
[19193822] J Am Osteopath Assoc 109(1): 26-36 (2009)
2009  
5
Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia.
[19436668] Vasc Health Risk Manag 5(1): 121-8 (2009)
2009  
6
Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review.
[19436644] Vasc Health Risk Manag 5(1): 225-31 (2009)
2006  
7
Insulin glargine in the treatment of type 1 and type 2 diabetes.
[17319470] Vasc Health Risk Manag 2(1): 59-67 (2006)
2006  
8
Insulin detemir in the treatment of type 1 and type 2 diabetes.
[17326333] Vasc Health Risk Manag 2(3): 277-83 (2006)
2000  
9
Genetically engineered insulin analogs: diabetes in the new millenium.
[10699152] Pharmacol Rev 52(1): 1-9 (2000)
2004  
10
Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.
[15525480] Health Technol Assess 8(45): iii, 1-57 (2004)
2001  
11
Recombinant DNA technology in the treatment of diabetes: insulin analogs.
[11588149] Endocr Rev 22(5): 706-17 (2001)
1998  
12
Insulin lispro (Humalog), the first marketed insulin analogue: indications, contraindications and need for further study.
[9627564] CMAJ 158(4): 506-11 (1998)
2008  
13
Cost-effectiveness of insulin analogs.
[18999911] Am J Manag Care 14(11): 766-75 (2008)
2009  
14
Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation.
[20144401] J Diabetes Sci Technol 3(6): 1451-9 (2009)
2010  
15
Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.
[20646668] Health Technol Assess 14(36): 1-248 (2010)
2009  
16
The role of insulin detemir in overweight type 2 diabetes management.
[19590589] Vasc Health Risk Manag 5(3): 553-60 (2009)
2007  
17
Review of biphasic insulin aspart in the treatment of type 1 and 2 diabetes.
[18200811] Vasc Health Risk Manag 3(6): 919-35 (2007)
2009  
18
Use of short-acting insulin aspart in managing older people with diabetes.
[19503780] Clin Interv Aging 4(-): 187-90 (2009)
2005  
19
Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.
[15793205] Diabetes Care 28(4): 950-5 (2005)
2011  
20
Long-acting insulin analogue detemir compared with NPH insulin in type 1 diabetes: a systematic review and meta-analysis.
[21878861] Pol Arch Med Wewn 121(7-8): 237-46 (2011)
2007  
21
New therapeutic options for treating type-2 diabetes: a review of insulin analogs and premixed insulin analogs.
[17444424] J Natl Med Assoc 99(4): 357-60, 363-7 (2007)
2005  
22
Systematic review and meta-analysis of short-acting insulin analogues in patients with diabetes mellitus.
[15983281] Arch Intern Med 165(12): 1337-44 (2005)
2010  
23
Insulin absorption from lipodystrophic areas: a (neglected) source of trouble for insulin therapy?
[20513344] J Diabetes Sci Technol 4(3): 750-3 (2010)
2009  
24
Insulin glargine controversy: a tribute to the editorial team at Diabetologia.
[19875618] Diabetes 58(11): 2427-8 (2009)
2006  
25
Newer insulin analogues and inhaled insulin.
[16569928] Indian J Med Sci 60(3): 117-23 (2006)
2007  
26
Insulin glargine in the management of diabetes mellitus: an evidence-based assessment of its clinical efficacy and economic value.
[21221178] Core Evid 2(2): 89-110 (2007)
2010  
27
The role of insulin glulisine to improve glycemic control in children with diabetes mellitus.
[21437110] Diabetes Metab Syndr Obes 3(-): 403-12 (2010)
2009  
28
Analog insulin detemir for patients with type 1 and type 2 diabetes: a review.
[21437117] Diabetes Metab Syndr Obes 2(-): 31-6 (2009)
2007  
29
2010  
30
Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs.
[21701633] Drug Healthc Patient Saf 2(-): 213-23 (2010)
2011  
31
An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia.
[21481127] Diabetes Obes Metab 13(9): 814-22 (2011)
2011  
32
Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review.
[21978524] Cost Eff Resour Alloc 9(1): 15 (2011)
2011  
33
Albumin binding ligands and albumin conjugate uptake by cancer cells.
[21676260] Diabetol Metab Syndr 3(1): 11 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



Search PubMed and many other databases on the combined search terms

GG: insulin analogs
GG: acting insulin

  • Diabetes mellitus (t Insulin Analoga)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia